Incorporating a Patient Dichotomous Characteristic in Cancer Phase I Clinical Trials Using Escalation with Overdose Control
Figure 1
Histogram and fitted density (dashed line) of dose allocations for patients 2 through 80 based on 1000 simulated trials using the model with covariate. The true MTDs are , , and , , .